Yardstik Raises $30M in Series B to Tackle the Post-Hire Blind Spots and Workforce Fraud

Yardstik raised $30M in new funding, led by Harbert Growth Partners, lifting total capital raised to $65M. The company plans to expand fraud prevention and continuous workforce monitoring (e.g., motor vehicle reports, OIG exclusion monitoring, automated alerts for expiring licenses/insurance/certifications), complementing its newly released Fraud Insights and Continuous Monitoring features. The round follows 149% YoY revenue growth and a 99.4% customer satisfaction score, and the article highlights 98% account retention over the past three years—signals of strong momentum in employer workforce risk management.

Analysis

This is more of a category-validation event than a direct equity catalyst. The investable signal is that compliance is shifting from a low-frequency screening fee to a recurring workflow subscription, which expands the TAM for platform-native vendors and compresses the moat of pure point-solution screeners. In public markets, that tends to reward broader HR software owners and punish niche vendors whose economics depend on manual rechecks, premium monitoring add-ons, and high service intensity.

The second-order effect is distribution, not just product: whoever sits inside the ATS/HRIS workflow can monetize trust at lower CAC and higher retention. That should favor ADP and PAYX over standalone screening names on a 6-18 month view, while vendors with narrower exposure to staffing/gig/logistics could see pricing pressure if customers insist on "always-on" monitoring as a bundled feature. The near-term reaction is likely muted because this is private capital, but the 1-3 month catalyst path is any commentary from public screening companies about mix shift, attach rates, or discounting.

Contrarian view: the market may overestimate how quickly employers will pay for continuous monitoring once false positives, admin burden, and privacy friction show up. If the signal quality is noisy, buyers will treat it as a compliance checkbox rather than a budget expansion, which caps ARPU upside. The thesis is falsified if public screeners sustain recurring-revenue growth without margin dilution or if HR suites fail to convert workflow control into incremental monetization.

Key Decisions for Investors

• No direct trade in CRMT/TLSS/TSTS; the article is too indirect for a single-name equity expression. Treat as an alert on the broader HR compliance stack rather than a catalyst.
• Use any 3-5% post-news strength in FADV or HRT to initiate a small short or buy put spreads, targeting 8-12% downside over 1-3 months if management commentary points to pricing pressure from embedded monitoring features.
• Prefer a relative-value long ADP or PAYX vs. short FADV/HRT over the next 3-6 months. Thesis: workflow owners can bundle compliance and retain pricing power better than standalone screeners; stop if screening vendors show recurring revenue acceleration without margin erosion.
• Set an earnings-season watch item on attach rates, churn, and gross margin for public screening names. Cover shorts if recurring monitoring attach rates improve and customer retention stays above historical ranges despite competitive bundling.